Authors
Loading...
Computational screening study reveals novel MCH-R1 antagonist chemotypes using ligand-steered modeling, indicating a tenfold improvement over random screening.
Cavasotto et al. (2008) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: